chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Trouble Breathing, Body aches, Chills, Mild Fever, General Malaise, Diarrhea, Vomiting
Hospitalized (10.21.21 - still admitted / current);  COVID-19 positive (10.21.21); fully vaccinated  Date of Admission: 10/21/2021 Chief complaint Diarrhea due to COVID-19 History of Present Illness Patient is a 81 y.o. female who presents today with diarrhea.  Patient has a history of chronic respiratory failure with hypoxia on 2 L nasal cannula baseline, chronic obstructive pulmonary disease, history of DVT/PE on Eliquis, hypothyroid, squamous cell lung cancer, type 2 diabetes, obesity.  She is mostly wheelchair bound.  She lives at home alone and has visiting nurses who come twice a day.  Per patient, she began having diarrhea about 4 days ago, which is very frequent and yellow in color.  She states that her rectal and buttock area is very painful and brought this point.  She has noted some mild shortness of breath and more coughing and states that every time she coughs she passes stool.  She denies any fevers/chills, abdominal pain, nausea/vomiting.  She has had decreased appetite over the past few days.  Her daughter, who is a caregiver tested positive for COVID recently.  The patient is vaccinated. In the emergency department, the patient was found to be hemodynamically stable.  She was on 2 L nasal cannula with saturations of 96%.  Labs were stable.  COVID testing was positive.  Initially, it was felt that the patient could go home, however, upon further discussion with the patient's family was felt that this was an unsafe discharge plan as the patient is home alone most of the day and cannot get to the bathroom herself.  Her daughter also tells me that the home health agency told them that nobody would be coming in tonight either.  Due to her very frequent diarrhea and inability to care for self, as well as not having a caregiver who is available to take care of her, it was felt that patient should be admitted for further observation.  Family feels that patient may benefit from a rehab facility. Progress note from 10.27.21: Covid-19 positive / infection Acute on chronic Hypoxic respiratory failure  Vaccination complete Sx onset 10/17/21 (daughter with Covid) Covid + 10/21/21 Baseline 2L NC for COPD increased to 4 then 6 so started tx Decadron 6 d x10 d  Remdesivir x5 d
Within 4 hours, my temperature spiked. I slept for long periods of time only to awake and fall back asleep. My tempt continue to spike. I was unable to keep anything down - no water, no Tylenol. This continued for 48 hours. My face was brilliant red and swollen. I couldn't walk more than 10 ft. I lost 6 pounds. I had diarrhea and nauseous. After 2 days of being unable to move, walk or talk, I was able to sit-up. The next day, when I got out of bed, I almost fainted. Back to bed. The second day, still very weak. The roof of my  mouth had blisters from the fever. I never took my temperature. I was too afraid. The fever was intense and came in ways.  It is six days since the vaccine and I am still weak.
Rash around eyes, including eye lids, mouth with edema. Then gradually spread around neck, trunk and diaper area. None on limbs and had fever. Vomiting formula but able to hold juice (4/26/05) clinically stable not in any apparent distress, alert and playful. But has URI and low grade fever. Gave Decadron 1cc IM rt
resident with acute SOB on 4/13 sent to ED dx with pneumonia. Sent to rehab. Passed away in her sleep on night of 4/20/21
Around 7:30 I began to have chills and slight back ache. In the hour following both got worse and I had full body aches. By 10:30pm after I had taken ibuprofen my temperature was 105.6 degrees and had a constant heart rate over 160bpm. I felt fatigued and shaky and had someone take me to hospital.
Client is 13 years old and accidently received a pediatric dose for Pfizer Covid-19 instead of an adult dose.
Patients that might have received an incomplete schedule of Menveo; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in unspecified number of patients who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The pharmacists reported that they had patients that might have received an incomplete schedule of Menveo. Till the time of reporting, the patients did not receive the dose of Menveo, which led to incomplete course of vaccination. The reporter consented to follow up via email. The healthcare professional had no data about patients or vaccines. This case had been linked with US2021094211, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021094211:Same reporter.
Pt felt dizzy & light headed.  c/o middle back hurts.       2:55 PM - Lymph nodes on throat felt swollen.  Noted tonsils are slightly enlarged but uvula is WNL & breathing w/o difficulty.  BP 146/79 P 59.      3PM - Left w/o assistance.
Post influenza vaccine, optic neuritis. Admitted to hospital 11/21/03 and discharged on 11/24/2003. The medical records received on 2/3/04 states headache, loss of vision, and amaurosis fugax. Discharge summary states disorder of pupil. msv
Pt has a knot that is palpable. About 1 inch in diameter. Pt denies pain, but was concerned about the reaction.
developed lupus three days after her second dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SYSTEMIC LUPUS ERYTHEMATOSUS (developed lupus three days after her second dose) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 027A21A) for COVID-19 vaccination.     Concomitant products included GABAPENTIN and ACICLOVIR SODIUM (ACYCLOVIR [ACICLOVIR SODIUM]) for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to dosage form. On 06-Apr-2021, the patient experienced SYSTEMIC LUPUS ERYTHEMATOSUS (developed lupus three days after her second dose) (seriousness criterion medically significant). The patient was treated with PREDNISONE ongoing since an unknown date at a dose of 20 milligram. At the time of the report, SYSTEMIC LUPUS ERYTHEMATOSUS (developed lupus three days after her second dose) outcome was unknown. Not Provided          Patient reported she was prescribed prednisone 20 mg all of last week, but she does not think it helped.  Company Comment  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-040998 (Patient Link).
Sore throat, cough, dizziness, fatigue, body aches, runny nose, throat congestion, headache, nausea, chills   Rested and took medicines
This spontaneous report has been received from a medical assistant referring to a female patient of one year old. There were no concomitant medications, drug reactions/allergies or pertinent medical history in regards to the patient. On 21-JAN-2019, the patient received a dose of M-M-R II (rHA) (lot#: R000557, expiration date: 8-JAN-2020; dosage and route not provided) along with sterile diluent for prophylaxis. On 22-JAN-2019, the patient developed hives. The reporter further reported that the patient was noted to have "hives all over" when seen by physician on 23-JAN-2019 and the patient was treated with "Hydroxyzine Hcl Oral", prescribed by the physician. No lab diagnostics were performed. The patient was currently not recovered. The causality assessment was not provided.
2 WEEKS AFTER - BOARDERLINE HEARING RESULTS FOR AT LEAST BETTER EAR, POOR TYMPANOMETRY MIDDLE EAR FUNCTION IN LT EAR, REFERED TO ENT FOR MIDDLE EAR DIFFICULTY.  LESS THEN 3 WEEKS AFTER VACCINATION, SOAR THROAT NOT EATING WELL CRANKY, FEVER OF 103.  ONE MORE DAY LATER, EAR DRAINAGE FROM LT EAR AND TROUBLE HEARING OUT OF RT.  3 MORE DAYS AND TEST FOR URI- DXED WITH URI AND AUDITORY FAILURE AND HEARING DIFFICULTY, NOT RESPONDING TO NOISES BEHIND HIM.  1 WEEK AFTER THIS TUBES PUT IN TO SEE IF IT HELPS WITH HEARING TO BRING BACK LANG.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a patient who received Influenza vaccine Quadrivalent unspecified season for prophylaxis. On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to Influenza vaccine Quadrivalent unspecified season. Additional details were reported as follows: The age at vaccination was not reported. The patient reported that, with every flu shot, the patient experienced a very sore arm. This case has been linked with case US2018GSK178901, reported by the same reporter.
Right arm puffy, shoulder to elbow, all the way around-"mushy", red, told to take ibuprofen by RN nurse advisor-symptoms went away after 24 hours.
EXTREME FATIGUE/TIRED; HEADACHE; FELT LIKE FLU FOR 5 DAYS; COULD NOT GET UP OR WORK; This spontaneous report received from a patient concerned a 78 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072, and batch number: 1802072 expiry: UNKNOWN) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced felt like flu for 5 days. On MAR-2021, the subject experienced could not get up or work. On 24-MAR-2021, the subject experienced headache. On 25-MAR-2021, the subject experienced extreme fatigue/tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache on 28-MAR-2021, was recovering from extreme fatigue/tired, and the outcome of felt like flu for 5 days and could not get up or work was not reported. This report was non-serious.
Patient experienced injection site pain that worsened for the past 4 days. Patient complains of pain so severe that she cannot move her arm.
This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second shot is past 42 days from first dose) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.Concurrent medical conditions included Hypertension and Type 2 diabetes mellitus. Concomitant products included METFORMIN for Diabetes, AMLODIPINE for Hypertension, DL- LACTIC ACID (EUCERIN [DL- LACTIC ACID]) and ATORVASTATIN for an unknown indication. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second shot is past 42 days from first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second shot is past 42 days from first dose) had resolved. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not provided. This case was linked to MOD-2021-216599 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Patient's demographic details, Patient's historical condition, concomitant products Metformin and Amlodipine details were added.
Participant reported waking up the next morning after his Pfizer vaccine with right facial paralysis and severe facial pain. Pt went to his primary care physician and was diagnosed with bell's palsy and instructed not to receive second dose of Pfizer.
Report A0374099A describes elevated amylase and lipase concentrations in a 36 year old female who received hep b vaccine recombinant. Medical history, concurrent conditions, and concurrent medications were not provided. On an unspecified date, the vaccinee received an injection of Engerix B (lot ENG5206B6); it was not known if she had received previous injections of Engerix B. Within 24 hours post-immunization, she experienced "severe" nausea and vomiting. Amylase and lipase concentrations were found to be elevated, and the vaccinee was hospitalized. Treatment and outcome were not provided.
Patient received his second Moderna shot in our location on 7/23/2021 around 3 pm.  On Saturday, 7/24 around 1130 am his daughter called to inform that his dad had fainted, got unconscious for approximately 1-2 minutes and was being transported to ER by emergency personnel at that precise moment for which she believes was adverse effects to his second Covid shot. I told her to keep me posted on that once he is stable.  Around 440pm on Saturday, 7/24/21, his wife and patient came over to pick up some medications that have been sent from the ER.  That included diphenhydramine, prochlorperazine and naproxen.  I asked them for more details previous to event, during event and what ER personnel had said.  Wife explained that he started with a headache and back pain the day after his shot and that he had not done anything different that morning.  Suddenly he fainted, his eyes turned white, his hands got twisted and he fell unconscious for 1 minute.  She said that it looked like an epilepsy episode but he did not have history of epilepsy or had anything like this before, as he was a healthy 38 y/o male. She explained to me that the only time he has been sick previously was when he got Covid infection late last year.  She explained that at the hospital he got CT scan test, blood work, chest X-Ray and EKG and everything was normal.
It has been discovered that patient was given an expired dose of MODERNA vaccine. The patient has not experienced an adverse event to the knowledge of clinical staff. MODERNA has been contacted to assess viability of vaccine.
Received the shot at the medical center at 1030am. I am a (Privacy) there and scheduled to work at 11am. I received my second shot and drank a few bottles of water. I started to get a headache but took some Motrin and finished the bottled water. By 1110 I felt off. I knew something more then a headache was happening to me. I had to go in the back in the break room and felt hot, dizzy, nauseas, vomiting in the garbage can, my ears felt hot, I felt sweaty. I remember feeling like I was going to die. I wanted to lie down and sat and put my head between my legs. I felt out of touch with myself. Someone got my manager and she came to see me. I remember saying I felt spinning. I wanted to get on the floor and that I was just hot and dizzy. I distinctly remember her asking me if I wanted to lay in my car with the AC on to cool down and that I responded along the lines of ?im afraid to be alone I?ll die?  another Co worker helped me call my husband who came to pick me up and I was sent home from my shift by 2pm I believe. I got home and immediately was vomiting in the bathroom off my garage entrance. My mother is also a (Privacy) ( recently retired who  watches my kids. She was extremely concerned and wanted me to go to the ER. I kept feeling if I went to the hospital I would die. I just wanted to lay down. I was vomiting so bad I urinated on myself.  I finally layed down and a few hours later was able to drink Gatorade and crackers.. over the next 1/2 l days I would have body aches, joint pain, chills, headache, and did a tele health visit with my dr - and he stated he felt this was a reaction to the second Covid vaccine- as within 45 minutes of the shot i became violently Ill. By the third to the fourth day I  then  began experiencing intermittent  chest discomfort/pain/pressure that would feel better when laying forward and worse if laying flat. I called my cardiologist and made an appointment the following week when my cardiac discomfort did not subside . The pain was a twinge little fluttering feeling sometimes quickly sharp then subsided in my left shoulder, chest, and sometimes quickly down my arm.  My cardiologist saw me Monday October 11th.  By then the pain was less frequent and more manageable.  He scheduled me for a routine echo. My echocardiogram was on Tuesday Oct 26th.. Wed December 8th was my follow up visit and he confirmed I did infact still have pericarditis on my echo cardio gram.
pt recv vax; devel red raised lesion at inject site & devel localized hives; reporter felt events were not related to varicella vax;
SkinRash, Rash, Diarrhea, Sweating, Feeling hot and tired Narrative: Patient received 4th COVID vaccine on 5/2/22 and received 3 prior vaccines as well. Pt has a history of COVID in Jan 2021. After 4th dose, pt had a large local reaction with induration at the injection site (erythematous, swollen) with systemic symptoms including "feeling hot and sweaty and tired and had diarrhea"
Information has been received from a nurse within the doctor's office concerning a female patient who was vaccinated with a second dose of GARDASIL.  The nurse reported that she heard from her aunt that a patient received the GARDASIL injection and experienced paralysis and could not even cut her own dinner after the injection was administered.  The patient had to walk with a cane and also went to physical therapy.  She did not receive the vaccine at the reporting nurse's office.  No further information was known.  The paralysis was considered to be disabling.  Additional information is not available.
Redness and swelling at injection site, erythemic area 8x7.5cm, Keflex for 10 days.
Injected on 1/20/14 and diagnosed with shingles on 4/30/14.
Pt vaccinated with Engerix-B developed gastritis, headache, neck pain, weakness.
received the shot and had no symptoms the first day. however the next day i did feel somewhat tired and had a red bump on my left arm and it hurt and looked like an ant bump. however later on that day i did feel as if i was being poked under my left arm and it hurt there for  another 24 hours or so. I took some advil to help the pain and it did. was told that i should report that because its not part of the regular symptoms that can happen.
Site: Redness at Injection Site-Medium, Systemic: Joint Pain-Medium, Additional Details: PT STATES REDNESS SPREAD FROM INJECTION SITE DOWN LEFT ARM THROUGH HAND. ELBOW PAIN, HAND PAIN, SQUEEZING HAND WAS HARD TO DO
I break out in hives all over my body in small areas for a short period of time (15-30 minutes). Sometimes it is random, other times it is after contact with any sort of surface, material, or abrasion
5 to 6 mon p/vax pt exp severe dizziness, blurred vision, muscle weakness, joint pain, endometriosis, Hashimoto's disease,  poor memory, faulty concentration, speech problems,arthritis
Patient stated his arm was swollen, red and had a fluid accumulation. Patient also was physically active after receiving the vaccine. He was going to be seen by his doctor for a routine checkup, and when his doctor saw it, they stated it was a "weird" reaction and that he should use Tylenol and apply heat. Patient states that after following doctor's instructions it is looking better.
4 vx given after delayed delivery due to inclimate weather; This case was reported by a other health professional via sales rep and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix pediatric) (batch number 95EJ7, expiry date 6th February 2023) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   In February 2022, the patient received Havrix pediatric .5 ml and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix pediatric and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. One to 2 years old patient received dose of Havrix pediatric from a shipment that had delayed delivery due to inclimate weather from 3rd February 2022 till 7th February 2022 but was still showing a good temperature tag alert in the box upon delivery to office.The Glaxosmithkline agreed to return and replace these vaccines on 9th February 2022 due to this longer than normal delivery window even though tag alert was still showing ok after 5 days in transit with this delivery on 7th February 2022. The reporter stated that, on 16th March 2022, learned from the GSK Vaccine Service Center that these 4 Havrix pediatric doses were not returned with rest of claim, and confirmed from the pediatric office on 17th March 2022 that these vaccines were administered to patient around the second week of February. The office was not extremely concerned due to good Glaxosmithkline temperature tag alert upon delivery. No adverse events or patient issues were reported after administration. There seems to be some internal Glaxosmithkline confusion with the temperature tag alerts after 4 days in transit. No evidence given that there was any temperature excursion during delayed delivery to compromise vaccine stability. The reporter consented to follow up. This case was one of 4 linked cases, reported by same reporter for different patients.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR049425:Same reporter. US-GLAXOSMITHKLINE-US2022AMR049480:Same reporter. US-GLAXOSMITHKLINE-US2022AMR049479:Same reporter. US-GLAXOSMITHKLINE-US2022AMR049479:Same reporter.
Pt. C/O pain at the site of injection as well as itchiness at the back of her left arm. No erythema was seen, no edema, no appearance of hives. Pt. stated she had severe pain in her arm after the first vaccine as well as fever to 101F but that symptoms subsided over the following 48 hours.
two days ago received 2nd dose of pfizer. This evening noticed large lymph node of left axilla, tender, unable to move left arm due to size. Pain. Fevers.
Tingling of mouth and tongue with subsequent swelling of tongue. Swelling of tongue lasted most of the evening. I treated the swelling with 5-6 doses of Benadryl throughout the evening. Tingling of mouth lasted for several days, then resolved and returned intermittently over the course of about 2 weeks. Within 2 days of the vaccine I developed a rash across most of my back that resolved after about a week, then returned to a milder extent about a week after initial resolution. A few days after the rash, I started experiencing tingling of my lower extremities that woke me up, that progressed to cramping of the legs. This occurred for several nights. My tongue continues to have a low level of tingling that has not gone away.  I notified my PCP of the event, but have not visited as there is not likely anything to be done and the majority of the symptoms with the exception of tingling of the tongue have resolved.
Headache, Fever, CHILLS, NJECTION SITE PAIN Narrative: